Minocycline and Magnesium As Neuroprotective Agents for Ischemic Stroke: A Systematic Review

Stroke is a leading cause of death, disability, and dementia worldwide. Strokes can be divided into ischemic strokes and hemorrhagic strokes. At the moment, tissue plasminogen activator (tPA) is the only FDA-approved drug for ischemic stroke. Minocycline (MC) and Magnesium (Mg) are promising therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz, Juan Fernando, Ruxmohan, Samir, Saxena, Alisha, Morillo Cox, Álvaro, Bashir, Farah, Tambo, Willians, Ghani, Mohammad R, Moya, Gustavo, Córdova, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837630/
https://www.ncbi.nlm.nih.gov/pubmed/33520535
http://dx.doi.org/10.7759/cureus.12339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837630/
https://www.ncbi.nlm.nih.gov/pubmed/33520535
http://dx.doi.org/10.7759/cureus.12339

Ejemplares similares